Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
Objective: Describe UK regional variation in prescription of anti-osteoporosis drug therapy before and after a primary hip fracture during 1999–2013.
Príomhchruthaitheoirí: | Shah, A, Prieto-Alhambra, D, Hawley, S, Delmestri, A, Lippett, J, Cooper, C, Judge, A, Javaid, M |
---|---|
Formáid: | Conference item |
Foilsithe / Cruthaithe: |
Springer Verlag
2016
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
de réir: Shah, A, et al.
Foilsithe / Cruthaithe: (2016) -
Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study
de réir: Shah, A, et al.
Foilsithe / Cruthaithe: (2016) -
Anti-osteoporosis medication prescriptions and incidence of secondary fracture amongst hip fracture patients in England and Wales: an age stratified interrupted time series analysis
de réir: Hawley, S, et al.
Foilsithe / Cruthaithe: (2018) -
Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted time-series analysis
de réir: Hawley, S, et al.
Foilsithe / Cruthaithe: (2016) -
Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study
de réir: Hawley, S, et al.
Foilsithe / Cruthaithe: (2016)